SCHEMBL25516508

SCHEMBL25516508

c1ccc2c(c1)oc1cc(N(c3ccc4c(ccc5oc6ccccc6c54)c3)c3ccc4c(c3)sc3ccccc34)ccc12

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
AHR P35869 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
KDM4E B2RXH2 2/20 0.35
GPR3 P46089 1/20 0.34
NPC1 O15118 2/20 0.33
POLB P06746 1/20 0.32
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
MAOA P21397 1/20 0.31
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25871846 0.96 MAPT (0.39) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25871843 0.95 AHR (0.35) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25871845 0.95 MAPT (0.36) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25516299 0.93 TDP1 (0.40) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL24657637 0.93 L3MBTL1 (0.37) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25883825 0.93 MAPT (0.35) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25871954 0.93 ALDH1A1 (0.36) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25870727 0.93 MAPT (0.36) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25516307 0.93 ALDH1A1 (0.36) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25871658 0.92 HCRTR1 (0.34) MAPTALDH1A1HPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 US disclosed
WO-2023132694-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-07-13 WO disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR MAPT 2757/4885ALDH1A1 182/4885HPGD 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.